Table 2.
Comparison of major laboratory results between the CHB-MASLD and isolated CHB groups.
| Variable | CHB-MASLD (N = 188) | Isolated CHB (N = 998) | p Value |
|---|---|---|---|
| Hemoglobin (g/dL) | 14.1 ± 1.58 | 13.93 ± 1.72 | 0.13 |
| Platelets (×103/μL) | 209.7 ± 56.4 | 212.8 ± 59.4 | 0.52 |
| Aspartate aminotransferase (U/L) | 35 [19.3–89.0] | 31 [19–92] | <0.01 |
| Alanine aminotransferase (U/L) | 31 [22–97] | 26 [18–99] | <0.01 |
| Ferritin (ng/mL) | [181.5–50.1] 142.0 | [130.4–36.4] 77.2 | <0.01 |
| Bilirubin (g/dL) | 0.56 [0.44–0.78] | 0.59 [0.41–0.81] | 0.97 |
| Creatinine (mg/dL) | 0.88 ± 0.62 | 0.81 ± 0.41 | 0.07 |
| Triglycerides (mg/dL) | 147.7 ± 84.8 | 115.6 ± 71.5 | <0.01 |
| Low-density lipoprotein(mg/dL) | 111.9 ± 32.07 | 110.1 ± 34.4 | 0.48 |
| International normalized ratio (INR) | 1.01 ± 0.14 | 1.03 ± 0.34 | 0.36 |
Abbreviations: MASLD, metabolic-associatedsteatotic liver disease; CHB, chronic hepatitis B.